Associate Professor at Yeungnam University, South Korea
Associate Professor Dr. Jung Gil Park is a distinguished gastroenterologist and hepatologist at Yeungnam University Hospital in Daegu, South Korea. He earned his M.D. and Ph.D. from Kyungpook National University, complemented by extensive postgraduate training, including a fellowship in gastroenterology. Dr. Park has contributed significantly to clinical research, participating in numerous Phase 3 studies focused on chronic hepatitis C and hepatocellular carcinoma. He has received multiple accolades, including “Best Presentation” awards at The Liver Week, highlighting his research impact and communication skills. Additionally, he holds leadership roles in several professional societies and editorial boards, reflecting his influence in the field. Dr. Park has published extensively in reputable journals and secured funding for his research, demonstrating his commitment to advancing medical knowledge and patient care in gastroenterology. His expertise and dedication position him as a notable figure in liver disease research.
Professional Profile:
Education🎓
Associate Professor Dr. Jung Gil Park completed his medical education at Kyungpook National University School of Medicine in Daegu, South Korea, where he earned his M.D. in 2004. Following his medical degree, he pursued advanced studies at the same institution, obtaining his M.S. in 2015 and subsequently a Ph.D. in 2019, focusing on gastroenterology and hepatology. Dr. Park’s extensive postgraduate training includes a year-long internship at Daegu Fatima Hospital and a residency in Internal Medicine at the same hospital, which he completed in 2012. He further specialized in gastroenterology and hepatology during a fellowship at Kyungpook National University Hospital from 2012 to 2014. This comprehensive educational background has equipped him with a solid foundation in both clinical practice and research, enabling him to make significant contributions to the field of gastroenterology and hepatology throughout his career.
Professional Experience 💼
Associate Professor Dr. Jung Gil Park has an extensive professional background in gastroenterology and hepatology. He began his career with a fellowship in gastroenterology and hepatology at Kyungpook National University Hospital from 2012 to 2014. Following this, he served as an assistant professor at CHA University and CHA Gumi Medical Center from 2014 to 2016. Dr. Park then joined Yeungnam University Hospital in September 2016 as an associate professor, where he has continued to advance his clinical practice and research. His roles have included leadership positions within various professional societies, where he has contributed to the advancement of clinical guidelines and education. Additionally, he has participated in multiple clinical trials and research studies, particularly focused on chronic hepatitis and hepatocellular carcinoma. Dr. Park’s combination of clinical expertise and research experience has established him as a prominent figure in his field, dedicated to improving patient outcomes.
Research Interest🔍
Associate Professor Dr. Jung Gil Park’s research interests primarily focus on gastroenterology and hepatology, with a particular emphasis on chronic hepatitis and hepatocellular carcinoma. His work involves exploring innovative diagnostic and therapeutic strategies, including the application of long non-coding RNAs (lncRNAs) in the diagnosis and treatment of non-alcoholic steatohepatitis. Dr. Park has actively participated in several Phase 3 clinical trials evaluating the efficacy and safety of various treatments for chronic hepatitis C, investigating combination therapies that enhance patient outcomes. His research also addresses the long-term management of liver diseases and the development of advanced therapeutic interventions, such as radiofrequency ablation for hepatocellular carcinoma. Through his clinical studies, Dr. Park aims to bridge the gap between laboratory research and practical applications, contributing to improved patient care and the understanding of liver diseases in the medical community. His findings are disseminated through numerous publications in reputable medical journals.
Awards and Honors
Associate Professor Dr. Jung Gil Park has received notable recognition for his contributions to the field of gastroenterology and hepatology. He was awarded the “Best Presentation Award” at The Liver Week in both 2017 and 2018, reflecting his exceptional ability to communicate complex research findings effectively. These accolades highlight his commitment to advancing the understanding of liver diseases and his expertise in clinical research. Additionally, Dr. Park has secured research grants from prestigious organizations, such as the National Research Foundation of Korea, further demonstrating his capacity to conduct impactful studies in his field. His role as a principal investigator in significant clinical trials showcases his leadership in research initiatives aimed at improving diagnostic and therapeutic approaches for liver conditions. Dr. Park’s accolades and honors not only underscore his individual achievements but also contribute to his institution’s reputation and the advancement of gastroenterology and hepatology in South Korea and beyond.
Conclusion
Jung Gil Park’s qualifications and accomplishments make him a strong candidate for the Best Researcher Award. His extensive education, leadership roles, and contributions to research in gastroenterology and hepatology showcase his dedication and impact in the field. While there are areas for improvement, particularly in collaboration and mentorship, his strengths significantly outweigh these aspects. Dr. Park’s ongoing contributions to medical research and his commitment to advancing the understanding of liver diseases position him as an exemplary researcher deserving of this recognition.
Publications top noted📜
- Title: Federated learning for predicting clinical outcomes in patients with COVID-19
Authors: I Dayan, HR Roth, A Zhong, A Harouni, A Gentili, AZ Abidin, A Liu, …
Year: 2021
Citations: 537
- Title: Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma
Authors: YR Lee, G Kim, WY Tak, SY Jang, YO Kweon, JG Park, HW Lee, YS Han, …
Year: 2019
Citations: 233
- Title: Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: a Korean nationwide, multicenter, retrospective, observational, cohort study
Authors: JG Park, WY Tak, SY Park, YO Kweon, SY Jang, YR Lee, SH Bae, …
Year: 2017
Citations: 80
- Title: Deep metric learning-based image retrieval system for chest radiograph and its clinical applications in COVID-19
Authors: A Zhong, X Li, D Wu, H Ren, K Kim, Y Kim, V Buch, N Neumark, B Bizzo, …
Year: 2021
Citations: 71
- Title: Federated Learning used for predicting outcomes in SARS-COV-2 patients
Authors: M Flores, I Dayan, H Roth, A Zhong, A Harouni, A Gentili, A Abidin, A Liu, …
Year: 2021
Citations: 54
- Title: Effects of branched-chain amino acid (BCAA) supplementation on the progression of advanced liver disease: a Korean nationwide, multicenter, prospective, observational, cohort study
Authors: JG Park, WY Tak, SY Park, YO Kweon, WJ Chung, BK Jang, SH Bae, …
Year: 2020
Citations: 49
- Title: Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non‐alcoholic fatty liver disease
Authors: JG Park, J Jung, KK Verma, MK Kang, E Madamba, S Lopez, …
Year: 2021
Citations: 47
- Title: Prospective validation of Baveno V definitions and criteria for failure to control bleeding in portal hypertension
Authors: SY Ahn, SY Park, WY Tak, YR Lee, EJ Kang, JG Park, WK Lee, K Lee, …
Year: 2015
Citations: 43
- Title: Early complications after percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1,843 ablations in 1,211 patients in a single centre: experience …
Authors: JG Park, SY Park, WY Tak, YO Kweon, SY Jang, YR Lee, K Hur, HJ Lee, …
Year: 2017
Citations: 41
- Title: Severity and consolidation quantification of COVID-19 from CT images using deep learning based on hybrid weak labels
Authors: D Wu, K Gong, CD Arru, F Homayounieh, B Bizzo, V Buch, H Ren, K Kim, …
Year: 2020
Citations: 38
- Title: Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinoma
Authors: JS Yoon, G Kim, YR Lee, SY Park, WY Tak, YO Kweon, JG Park, HW Lee, …
Year: 2018
Citations: 38
- Title: A multi-center study of COVID-19 patient prognosis using deep learning-based CT image analysis and electronic health records
Authors: K Gong, D Wu, CD Arru, F Homayounieh, N Neumark, J Guan, V Buch, …
Year: 2021
Citations: 36
